Manulife (Manufacturers Life Insurance)
ROIV icon

Manulife (Manufacturers Life Insurance)’s Roivant Sciences ROIV Stock Holding History

Manulife (Manufacturers Life Insurance)’s Portfolio ROIV Stock Details ROIV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$106M Buy
2,988,121
+2,288,984
+327% +$67.6M 0.08% 229
2026
Q1 		$19.4M Buy
699,137
+100,622
+17% +$2.58M 0.02% 612
2025
Q4 		$13M Buy
598,515
+131,316
+28% +$2.59M 0.01% 770
2025
Q3 		$7.07M Buy
467,199
+81,250
+21% +$1.01M 0.01% 1037
2025
Q2 		$4.35M Buy
385,949
+54,147
+16% +$587K ﹤0.01% 1225
2025
Q1 		$3.35M Sell
331,802
-6,211
-2% -$67.2K ﹤0.01% 1311
2024
Q4 		$4M Sell
338,013
-18,587
-5% -$220K ﹤0.01% 1288
2024
Q3 		$4.12M Buy
356,600
+34,641
+11% +$394K ﹤0.01% 1286
2024
Q2 		$3.4M Sell
321,959
-77,925
-19% -$854K ﹤0.01% 1318
2024
Q1 		$4.21M Buy
399,884
+110,073
+38% +$1.19M ﹤0.01% 1260
2023
Q4 		$3.25M Buy
289,811
+38,799
+15% +$378K ﹤0.01% 1321
2023
Q3 		$2.93M Buy
+251,012
New +$2.84M ﹤0.01% 1322

Other funds holding ROIV

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
QF
QVT Financial New York $1.7B AUM 173.77% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return
FCM
Farallon Capital Management San Francisco, California $21.7B AUM 79.24% 1-Year Est. Return

Manulife (Manufacturers Life Insurance)'s ROIV Position: Q2 2026 in Review

Manulife (Manufacturers Life Insurance) increased its Roivant Sciences (ROIV) stake by 327% in Q2 2026, buying an estimated $67.6M and bringing the position to 2,988,121 shares worth $106M. The position accounts for 0.08% of the portfolio, ranked #229.

Manulife (Manufacturers Life Insurance) first reported a position in ROIV in Q3 2023 and has held it in 12 quarters since. 498 funds tracked by Wall St. Rank hold ROIV as of Q2 2026.

  • Manulife (Manufacturers Life Insurance) held 2,988,121 shares of Roivant Sciences worth $106M as of Q2 2026.
  • Manulife (Manufacturers Life Insurance) bought 2,288,984 Roivant Sciences shares in Q2 2026, an estimated $67.6M.
  • Roivant Sciences made up 0.08% of Manulife (Manufacturers Life Insurance)'s portfolio in Q2 2026, its #229 holding.
  • Manulife (Manufacturers Life Insurance) first reported a position in Roivant Sciences in Q3 2023 and has held it in 12 quarters since.
  • 498 funds tracked by Wall St. Rank held Roivant Sciences as of Q2 2026.

Based on Manulife (Manufacturers Life Insurance)'s 13F filing for Q2 2026, filed 14 Aug 2026.